Skip to main content
OpenTrials
Completed

NCT Number: NCT00768833

Study Evaluating the Nasopharyngeal Carriage in Healthy Children

The purpose of this study is to assess the prevalence of pneumococcal stereotypes in the nasopharynx of healthy children and to describe the changes of nasopharyngeal carriage at different ages over time.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Healthy Subjects

Age range

3 month–4 month

Sex eligibility

All sexes

Study type

Observational

Primary location

Pfizer Investigational Site

Offenbach, 63069, Germany

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Main inclusion criteria:

  • Age at enrolment 3 to 4 month Main

Exclusion criteria

  • Malformation or injury of the nasopharynx
  • Known or suspected immunodeficiency
  • Relevant immunosuppression
  • Use of antibiotics up to 10 days prior to study inclusion

Treatment and study plan

Primary outcomes

  1. Number and frequency of S. pneumonia positive serotypes

    Time frame: 57 months

Secondary outcomes

  1. Changes in number and frequency of S. pneumonia positive children at different ages over time

    Time frame: 57 month

Sponsors and collaborators

Lead sponsor

Pfizer

Industry

Registry information

Official study title

Nasopharyngeal Carriage in Children After Introduction of General Pneumococcal Immunization in Germany

Acronym: Carriage

Important dates

Study start
2008
Primary completion
2014
Study completion
2014
First posted
Oct 8, 2008
Registry last updated
Aug 21, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.